Catheter ablation for atrial fibrillation in the elderly >75 years old: Systematic review and meta-analysis
- PMID: 35589557
- DOI: 10.1111/jce.15549
Catheter ablation for atrial fibrillation in the elderly >75 years old: Systematic review and meta-analysis
Abstract
Introduction: Atrial fibrillation (AF) ablation is increasingly performed worldwide. As comfort with AF ablation increases, the procedure is increasingly used in patients that are older and in those with more comorbidities. However, it is not well established whether AF ablation in the elderly, especially those >75 years old, has comparable safety and efficacy to younger populations.
Objective: To compare the efficacy and safety profiles in patients older than 75 years undergoing AF ablation with younger patients.
Methods: Databases from EMBASE, Medline, PubMed, and Cochrane, were searched from inception through September 2021. Studies that compared the success rates in AF catheter ablation and all complications rates between patients who were older vs under 75 years were included. Effect estimates from the individual studies were extracted and combined using random effect, generic inverse variance method of DerSimonian and Laird.
Results: Twenty-seven observational studies were included in the analysis consisting of 363,542 patients who underwent AF ablation. Comparing patients older than 75 years old to younger patients, there was no difference in the success of ablation rates between elderly and younger patients (pooled OR 0.85: 95% CI:0.69-1.05, p = .131). On the other hand, AF ablation in the elderly was associated with higher complication rates (pooled OR 1.42: 95% CI:1.21-1.68, p < .001).
Conclusion: As AF ablation is expanded to elderly populations, our study found that AF ablation success rates were similar in both elderly and younger patients. However, older patients experience higher rates of complications that should be considered when offering the procedure and as a means to improve outcomes with future innovations.
Keywords: ablation; atrial fibrillation; complication; efficacy; elderly; older than 75 years.
© 2022 Wiley Periodicals LLC.
Similar articles
-
Efficacy and safety of catheter ablation for atrial fibrillation in elderly patients: a systematic review and meta-analysis.J Interv Card Electrophysiol. 2024 Oct;67(7):1691-1707. doi: 10.1007/s10840-024-01755-5. Epub 2024 Jan 31. J Interv Card Electrophysiol. 2024. PMID: 38291274
-
Efficacy and safety of high-power short duration atrial fibrillation ablation in elderly patients.J Cardiovasc Electrophysiol. 2022 Jul;33(7):1425-1434. doi: 10.1111/jce.15504. Epub 2022 May 6. J Cardiovasc Electrophysiol. 2022. PMID: 35441414
-
Atrial fibrillation catheter ablation in endurance athletes: systematic review and meta-analysis.J Interv Card Electrophysiol. 2024 Mar;67(2):329-339. doi: 10.1007/s10840-023-01574-0. Epub 2023 Jul 19. J Interv Card Electrophysiol. 2024. PMID: 37466821
-
Catheter Ablation for Atrial Fibrillation in Elderly Patients: an Updated Meta-analysis of Comparative Studies.Can J Cardiol. 2024 Dec;40(12):2441-2451. doi: 10.1016/j.cjca.2024.08.263. Epub 2024 Aug 9. Can J Cardiol. 2024. PMID: 39127258
-
Safety and efficacy of catheter ablation of atrial fibrillation in the very elderly (≥80 years old): Insights from the UC San Diego AF Ablation Registry.Clin Cardiol. 2023 Dec;46(12):1488-1494. doi: 10.1002/clc.24137. Epub 2023 Aug 25. Clin Cardiol. 2023. PMID: 37626475 Free PMC article.
Cited by
-
Temporal trends of catheter ablation procedures in patients with atrial fibrillation and atrial flutter: A nationwide cohort study.Int J Cardiol Heart Vasc. 2024 Oct 23;55:101541. doi: 10.1016/j.ijcha.2024.101541. eCollection 2024 Dec. Int J Cardiol Heart Vasc. 2024. PMID: 39507295 Free PMC article.
-
Linear accelerator-based stereotactic arrhythmia radioablation for paroxysmal atrial fibrillation in elderly: a prospective phase II trial.Europace. 2023 Dec 6;25(12):euad344. doi: 10.1093/europace/euad344. Europace. 2023. PMID: 37988294 Free PMC article. Clinical Trial.
-
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.J Interv Card Electrophysiol. 2024 Aug;67(5):921-1072. doi: 10.1007/s10840-024-01771-5. J Interv Card Electrophysiol. 2024. Corrected and republished in: Heart Rhythm. 2024 Sep;21(9):e31-e149. doi: 10.1016/j.hrthm.2024.03.017. PMID: 38609733 Corrected and republished.
-
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.Europace. 2024 Mar 30;26(4):euae043. doi: 10.1093/europace/euae043. Europace. 2024. Corrected and republished in: Heart Rhythm. 2024 Sep;21(9):e31-e149. doi: 10.1016/j.hrthm.2024.03.017. PMID: 38587017 Free PMC article. Corrected and republished.
-
Catheter ablation of concomitant atrial fibrillation improves survival of patients undergoing transcatheter edge-to-edge mitral valve repair.Front Cardiovasc Med. 2023 Aug 14;10:1229651. doi: 10.3389/fcvm.2023.1229651. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37645518 Free PMC article.
References
REFERENCES
-
- Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114(9):1453-1468.
-
- Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155(5):469-473.
-
- Newgard CB, Sharpless NE. Coming of age: molecular drivers of aging and therapeutic opportunities. J Clin Invest. 2013;123(3):946-950.
-
- Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321(13):1261-1274.
-
- Kewcharoen J, Prasitlumkum N, Chokesuwattanaskul R, et al. Ablation versus medication as initial therapy for paroxysmal atrial fibrillation: an updated meta-analysis of randomized controlled trials. J Arrhythm. 2021;37(6):1448-1458.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials